GSK plc Adjustments For Share-based Payments
GSK plc (GLAXF) reported Adjustments For Share-based Payments of GBP 374.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2026-03-06
| Period end | Adjustments For Share-based Payments 12 month | Adjustments For Share-based Payments 12 month as first filed |
|---|---|---|
| 2025-12-31 | 374.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 344.00M GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | 307.00M GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | 346.00M GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | 343.00M GBP 20-F · filed 2024-03-05 | 367.00M GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 337.00M GBP 20-F · filed 2023-03-10 | 381.00M GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 365.00M GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | 360.00M GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | 333.00M GBP 20-F · filed 2020-03-06 | |
| 2016-12-31 | 319.00M GBP 20-F · filed 2019-03-15 | |
| 2015-12-31 | 368.00M GBP 20-F/A · filed 2018-03-20 |